7-100072186-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032924.5(ZNF3):āc.298C>Gā(p.Gln100Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,595,474 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032924.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF3 | NM_032924.5 | c.298C>G | p.Gln100Glu | missense_variant | 6/6 | ENST00000299667.9 | NP_116313.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF3 | ENST00000299667.9 | c.298C>G | p.Gln100Glu | missense_variant | 6/6 | 1 | NM_032924.5 | ENSP00000299667.4 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152142Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000243 AC: 56AN: 230746Hom.: 0 AF XY: 0.000295 AC XY: 37AN XY: 125426
GnomAD4 exome AF: 0.000141 AC: 204AN: 1443214Hom.: 2 Cov.: 32 AF XY: 0.000153 AC XY: 110AN XY: 717634
GnomAD4 genome AF: 0.000309 AC: 47AN: 152260Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.298C>G (p.Q100E) alteration is located in exon 6 (coding exon 4) of the ZNF3 gene. This alteration results from a C to G substitution at nucleotide position 298, causing the glutamine (Q) at amino acid position 100 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at